Please register using the links below. We look forward to your participation!
Dates & Times |
Topic |
Presenters |
Registration |
| Fri, Jun 26 at 3:00pm EST |
The Role of Culture in Creating a TMS Center of ExcellenceLeveraging people, processes, and your environment to establish a high standard of care |
Dr. Walt Duffy
Alivation
|
 |
| Wed, Jul 8 at 8:00pm EST |
TMS & Ketamine: A Synergistic Approach to Psychiatric TreatmentClinical data and operational experience supporting their concurrent use |
Dr. Sandhya Prashad
Houston TMS & Ketamine Therapeutics
|
|
Topic |
Presenters |
Watch Now |
A New Era in OCD Treatment: Clinical Evidence for Deep TMSLearnings from a multicenter, double-blind, randomized controlled trial |
Dr. David Feifel
Kadima Neuropsychiatry
|
 |
Standing Out: Building a Successful TMS Practice with MarketingStrategies proven to generate patients and build referral networks |
Dr. David Kent
NuMe TMS Clinics
|
|
Navigating Reimbursement for Deep TMSHow to verify benefits, complete prior authorizations, submit claims, and handle appeals |
Andrea Raynor
Brainsway - Palomino Group
|
|
Evaluating TMS Technologies: Deep vs. Standard Figure-8Explore the differences from a technological, clinical, operational usage, and financial perspective |
Dr. Raul J. Rodriguez
Delray Center for Healing
|
|
Deep vs. Standard rTMS for MDD: An Independent Head-to-Head RCTAn in-depth analysis of the first trial comparing Deep TMS, Standard Figure-8 TMS, and medication in depression patients |
Tal Harmelech, PhD
BrainsWay
|
|
Psychiatric Practice During the COVID-19 PandemicBest practices for managing your patients' mental health conditions during a public health crisis |
Dr. Aron Tendler
Advanced Mental Health
Dr. Geoffrey Grammer
Greenbrook TMS
|
|
Staying Afloat: Navigating Depression & Anxiety During the COVID-19 PandemicStrategies and treatment options for coping during a public health crisis |
Dr. Reid Robison
Cedar Psychiatry
Dr. Adele Lafrance
Laurentian University
|
|
Running an Efficient Deep TMS PracticeBest practices for managing operations and maximizing productivity of a TMS practice |
Dr. David Kent
NuMe TMS Clinics
|
|
Preparing for the Post COVID-19 Storm: Clinical, Financial, and Operational Considerations for PsychiatristsHow technology revolutionized and will further change psychiatry after COVID-19 |
Dr. Owen Muir
Brooklyn Minds
|
|
Qualifying and Converting Patient Leads for Deep TMSStrategies to properly convert an inquiry into a Deep TMS patient during this time and beyond
|
Monique Black
Mindy Dicrosta
Mental Health Strategies & Solutions (MHSS)
|
|
Develop a Successful Practice in a Geography That is Not Familiar With TMSHow to increase patient acceptance for Deep TMS in your community |
Dr. Jean-Guy Gagnon
HeadWay Clinic
|
|
Integrative Mental Health Treatment in the 21st CenturyMedical devices, pharmacotherapy, psychotherapy, and holistic approaches to mental health treatment |
Dr. Saad Shakir
Silicon Valley TMS
|
|
Brain Stimulation in the Study & Treatment of AddictionFrom animal studies to the report of BrainsWay's Smoking Cessation Multicenter Study |
Abraham Zangen, PhD
BrainsWay
|
|
Foundations for a Successful Deep TMS PracticeBrainsWay's Practice Development Managers outline how to build the capabilities that lead to success |
Chavi Bhardwaj
Christine Thomas
Victoria Cruz
BrainsWay
|
|
Deep Transcranial Magnetic Stimulation for Psychiatric DisordersNeurostimulation options available to treat psychiatric conditions, including their neurobiological basis |
Dr. Dorothy Reddy
Neurogenex
|
|
Beyond Therapy: Deep TMS for Treatment-Resistant MDD & OCD PatientsHow limitations of psychotherapy and medication can be overcome with Deep TMS |
Caleb Lack, PhD
University of Central Oklahoma
|
|
Advances in Neuromodulation for the Treatment of Neuropsychiatric ConditionsBrain stimulation options and ongoing research into the viability of Deep TMS for treating brain disorders |
Dr. Manish Sheth
Achieve TMS
|
|
Blossoming in a Post COVID-19 EraStrategies for successfully reopening and growing your practice after COVID-19 |
Veronique Coulombe
Medical Blossom
|
|
>1 in 3 depression patients achieved remission in a large scale double-blinded multicenter RCT, including those that had failed to achieve sufficient benefit from multiple medications and CBT. Learn more
>1 in 2 OCD patients achieved over a 20% reduction in symptoms in a large scale double-blinded multicenter RCT, including those that failed to achieve sufficient benefit from ERP or medication. Learn more
BrainsWay Deep TMS treatment for depression and OCD is a non-invasive, outpatient procedure. Sessions last approximately 20 minutes, no anesthesia is required, and patients are able to resume normal activities immediately after treatment.
Clinical trials that led to FDA-clearance demonstrated no systemic side effects, unlike antidepressants that have been shown in many cases to result in significant side effects, including nausea, insomnia, weight gain, fatigue, and even suicidal thoughts.
Deep TMS is not intended to replace evidence-based psychotherapy or medication, but rather offers a strong complementary medical device treatment option for patients that do not respond sufficiently to cognitive behavioral therapy, such as exposure-and-response prevention, or antidepressants alone.
Patients and clinicians report that in their practice, the use of Deep TMS has enabled patient's symptoms to improve to a degree that makes them more capable of participating fully in CBT exercises and complying with medication regimens.
Brainsway and the Brainsway logo are trademarks of Brainsway Ltd. © 2019 Brainsway. All Rights Reserved